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ABSTRACT
The Patient-Centered Outcomes Research Institute
(PCORI) recently launched PCORnet to establish a single
inter-operable multicenter data research network that
will support observational research and randomized
clinical trials. This paper provides an overview of the
patient-powered research networks (PPRNs), networks of
patient organizations focused on a particular health
condition that are interested in sharing health
information and engaging in research. PPRNs will build
on their foundation of trust within the patient
communities and draw on their expertise, working with
participants to identify true patient-centered outcomes
and direct a patient-centered research agenda. The
PPRNs will overcome common challenges including
enrolling a diverse and representative patient population;
engaging patients in governance; designing the data
infrastructure; sharing data securely while protecting
privacy; prioritizing research questions; scaling small
networks into a larger network; and identifying
pathways to sustainability. PCORnet will be the first
distributed research network to bring PCOR to national
scale.
INTRODUCTION
The Patient-Centered Outcomes Research Institute
(PCORI)1–3 recently launched an ambitious new
resource known as PCORnet, the National
Patient-Centered Clinical Research Network to
increase speed, efficiency, and relevance of clinical
research in the USA.4 In support of this initiative,
PCORI awarded $93.5 million to support 29 health
research networks (11 clinical data research net-
works (CDRNs) and 18 patient-powered research
networks (PPRNs)) that together will become a
large, interoperable, highly representative, national
‘network of networks’ for integrating patient-
generated data and electronic health information,
and conducting comparative effectiveness research
(CER).
PCORnet is a novel distributed data network that
includes substantial roles and responsibilities for
patients and their caregivers in building network
capacity, governing and using the health data, and
directing a patient-centered research agenda. By
encouraging and embedding patients in leadership
roles, PCORnet realigns the focus of the existing
clinical research enterprise from investigator-driven
to patient-centered, thereby advancing the PCORI
vision of a paradigm shift that powerfully expands
the currently limited roles of the patients and their
caregivers in clinical research participation and
decision-making. The PPRNs, networks operated
and governed by patients, advocacy organizations,
and their clinical research partners, will be leading
this shift within PCORnet and driving change into
our current translational research paradigm. This
paper provides a brief overview of the nascent
PPRN ecosystem.
EIGHTEEN PPRNS
In December 2013, PCORI awarded funding to 18
PPRNs that represent patients with a diverse set of
diseases and conditions (table 1). Half of the net-
works represent patients with rare diseases. The 18
PPRN abstracts are available at http://pcornet.org/
patient-powered-research-networks/.
PCORI has several goals for the PPRNs to
accomplish by the end of the 18-month funding
period. The PPRNs will:
▸ Enroll ≥0.5% of the US population with the
specified condition in their network, a
minimum of 50 000 patients for most common
conditions (less for patients with rare disorders).
▸ Develop a governance structure and operating
policies that fully involves the participants and
families, and fosters relationships with researchers
to generate and prioritize research questions
important to the network community’s
membership.
▸ Collect patient-generated health information
that is suitable for research from ≥80% of its
membership.
▸ Standardize data suitable for sharing with other
PCORnet networks.
To achieve these ambitious goals, PPRNs will
build on the strengths of their respective network,
including (1) a primary focus on improving the
health outcomes of individuals and their families,
(2) a strong foundation of cooperation, contribu-
tion, and trust among diverse stakeholders, and (3)
a high degree of participation by the participant
community to identify true patient-centered out-
comes and direct the research agenda. PPRNs will
bring the participant voice not only to their
respective networks, but to PCORnet as a whole.
The PPRN skills and expertise in engaging partici-
pants will serve as a powerful facilitator for robust
infrastructure development. We anticipate a variety
of challenges to implementation, however, some of
which are common within PCORnet and some of
which will be unique to individual PPRNs.
ENROLLING A DIVERSE AND REPRESENTATIVE
MEMBERSHIP
PPRNs aim to recruit participants with demo-
graphic and clinical characteristics sufficient to
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Table 1 Eighteen Patient-Powered Research Networks (PPRNs), PCORnet, December 2013
Network* Principal investigator Organization Disease or condition
Rare
disease
Type of organizations in the PPRN†
Group of
patients T1
Network by
researchers T2
Online
communities T3
Patient
registries T4
ALD Connect Florian Eichler Massachusetts General Hospital X-linked
adrenoleukodystrophy
● ● ●
American BRCA Outcomes and Utilization of
Testing Patient-Powered Research Network
(ABOUT Network)
Rebecca Sutphen University of South Florida
Morsani College of Medicine
Hereditary breast and
ovarian cancer
● ● ● ●
Arthritis Patient Partnership with Comparative
Effectiveness Researchers (AR-poWER PPRN)
Seth Ginsberg Global Healthy Living Foundation Inflammatory arthritis ● ●
CCFA Partners Patient Powered Research
Network
R. Balfour Sartor/
Michael Kappelman
Crohn’s and Colitis Foundation of
America
Inflammatory bowel disease ● ● ● ●
Community Engaged Network for All (CENA) Sharon Terry Genetic Alliance 10 disease network‡ ● ● ●
ImproveCareNow: A Learning Health System for
Children with Crohn’s Disease or Ulcerative
Colitis
Peter Margolis ImproveCareNow Network Inflammatory bowel disease ● ● ●
Mood Patient-Powered Research Network Andrew Nierenberg Massachusetts General Hospital Mood disorders ● ●
Multiple Sclerosis Patient Powered Research
Network
Robert McBurney Accelerated Cure Project for MS Multiple sclerosis ● ●
NephCure Kidney Network for Patients with
Nephrotic Syndrome
Bruce Robinson Arbor Research Collaborative for
Health
Primary nephrotic syndrome ● ● ●
Patient Research Connection: PI-Connect Kathleen Sullivan Immune Deficiency Foundation/
USIDNET
Primary immunodeficiency ● ● ●
Patients, Advocates and Rheumatology Teams
Network for Research and Service (PARTNERS)
Consortium
Laura Schanberg/Esi
Morgan Dewitt/Marc
Natter
Duke University Medical Center/
PARTNERS
Pediatric rheumatic disease ● ● ● ● ●
Phelan-McDermid Syndrome Data Network Megan O’Boyle/Lyz
Horn/Paul Avillach
Phelan-McDermid Syndrome
Foundation/Harvard Medical
School
Phelan–McDermid syndrome ● ● ● ●
Rare Epilepsy Network (REN) Janice Buelow Epilepsy Foundation Catastrophic rare epilepsies ●
Sleep-Apnea-Patient Centered OutcomesNetwork
(SA-PCON)
Susan Redline Brigham and Women’s Hospital Sleep apnea ● ●
The COPD Patient Powered Research Network John Walsh/Richard
Mularski
The COPD Foundation & Kaiser–
The Center for Health Research
Chronic obstructive
pulmonary disease
● ●
The DuchenneConnect Patient-Report Registry
Infrastructure Project
Holly Peay Parent Project Muscular
Dystrophy
Duchenne and Becker
muscular dystrophies
● ● ● ●
The Health eHeart Alliance Mark Pletcher University of California, SF Cardiovascular health ● ●
The Vasculitis Patient Powered Research Network Peter Merkel University of Pennsylvania Vasculitis ● ● ●
T1 US-based network, group, or organization of patients (either with a physical or virtual presence) of any size that has as a central goal of the establishment and growth of an activated cadre of individuals to provide their own patient-reported data
for PCOR.
T2 Networks or groups that have been developed in part through the efforts of clinicians, researchers, or delivery systems to participate in comparative effectiveness research, including randomized clinical trials. These are networks or groups that were
not initiated or managed by patients and/or family members.
T3 Networks or groups of patients that have been convened through the efforts of internet-based or social media-based vendors, such as online communities, groups convened to use personal health records, or specifically for purposes of participating
in research.
T4 Existing patient registries in which member patients are active in the governance of registry activities and management of the registry data. These registries were initiated by patients and/or family members.
*Abstracts for each PPRN can be found in the online JAMIA supplement for this manuscript or at http://pcornet.org/patient-powered-research-networks/.
†*Each project can be built from multiple organizations.
‡Alström syndrome, dyskeratosis congenita, Gaucher disease, hepatitis, inflammatory breast cancer, Joubert syndrome, Klinefelter syndrome and associated sex chromosome conditions, metachromatic leukodystrophy, pseudoxanthoma elasticum, and
psoriasis.
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represent the range of expression of the conditions, and the
lived experience of affected individuals and their families.
PPRNs are developing strategies to reach historically under-
represented groups defined in terms of race/ethnicity, socio-
economic status, geographic location, and health literacy, as well
as address the needs of patients across a wide range of clinical
severity. While each PPRN has a unique approach, strategies to
enhance the diversity and the representativeness of their com-
munities include working with community or faith-based groups
to engage underserved patients, developing language and liter-
acy level appropriate recruitment and risk/benefit materials
(print, video, audio, electronic), and engaging communities in
traditionally underserved geographic areas.
ENGAGING PARTICIPANTS IN THE GOVERNANCE OF THEIR
RESEARCH NETWORKS
PPRNs will have governance structures that rely on patient rep-
resentation and participation. Affected individuals and their
families, along with other stakeholders, will set policies with
regard to data use and data sharing within and across the net-
works, create strategic priorities, and participate in the design
and execution of research and its application. While some
PPRNs have patients or parents as principal investigators as well
as long histories of participant governance, many PPRNs will
need to refine or create governance structures and processes that
ensure meaningful participant engagement, transparent decision-
making, and robust prioritization methods. Attention to engage-
ment principles may be especially relevant in a networked age,
with online communities that are more open and diffuse.
Engagement with participants may be through ‘virtual’ or digital
media, providing opportunities to reach millions of patients,
while challenging existing paradigms based on direct personal
contact.
DESIGNING THE DATA INFRASTRUCTURE AND DATA
COLLECTION APPROACHES
Enabling participants to collect and use their own data
PPRNs will include mechanisms through which participants can
collect and use their own health data. For example, some
PPRNs will provide participants with the opportunity to directly
enter their information into online surveys within a patient
portal, upload data from remote monitoring devices (and
sensors), or enter their health data generated by mobile health
applications. Some of this patient-generated data may be used
for clinical research, and may also help facilitate self-
management. Many PPRNs will develop interactive portals that
help participants track their exposures and health outcomes
over time to gain insights about triggers and recurring symp-
toms that may further inform conversations with treating
physicians.
PPRN members may also be able to share their own electronic
health data directly (obtained by providers and hospitals
through the View, Download, Transmit (VDT) requirements on
Meaningful Use or the Blue Button functions offered by health
plans and other data holders). For some PPRNs, however, elec-
tronic health record (EHR) data may not be sufficiently granular
to capture the clinical condition of interest. Moreover, the
ontology for a particular disease may not yet be captured in a
standardized format in the medical records. Thus, linking longi-
tudinal data collected by PPRNs from multiple data sources,
such as data provided through patient reports, claims data from
CMS or private health insurers, clinical registry data, and EHR
data is essential,5 and finding ways to enable these linkages will
be explored and implemented.
Standardizing the collection of patient health data and
mapping to the PCORnet common data model
To enable the technical and analytic success of conducting
research within PCORnet, a set of data domains will need to be
standardized across network partners. In the initial stages,
PCORnet will standardize a format for a limited set of demo-
graphic data, vital signs, and clinical diagnoses or conditions to a
common data model that will allow for multicenter distributed
analytics. The PCORnet common data model will not require
mapping to a specific clinical terminology, but rather will allow
partners to leave the clinical data in the format it was collected
(eg, ICD9-CM, ICD9 procedures, HCPCS, SNOMED, LOINC).
When harmonization of specific code sets is required (eg, race,
smoking status, sex), PCORnet will adopt the relevant national
standard for that code set, or select from the several relevant
standards based on input from partners and other stakeholders.
PCORnet will draw from the experience of the numerous exist-
ing distributed networks that use a common data model approach
to facilitate complex distributed analytics (eg, HMO Research
Network, Vaccine Safety Datalink, and Mini-Sentinel).
The standardization and effective use of patient-generated
information, however, provides a formidable challenge, as no
standardized ontology or lexicon has been created for the vast
majority and range of data elements. PCORnet will provide the
infrastructure to create new processes and approaches to the
standardization and mapping of these important, yet difficult to
incorporate domains, enabling reliable querying across data
sources in later phases of development.
ENGAGING PATIENTS IN SHARING THEIR DATA SECURELY
WHILE PROTECTING PRIVACY
Attention to security and privacy is critical to develop and
sustain patient trust and encourage research participation. The
distributed data network approach allows sensitive patient data
to remain under the control of the PPRNs (and CDRNs) while
enabling analyses to happen behind their secure firewalls. The
analyses will typically generate aggregate results that are then
shared across networks. Additional security and privacy policies
and assurances will be developed by the PCORnet partners.
Some PPRNs are exploring a federated informed consent that
will be acceptable to multiple institutional review boards. Other
PPRNs will be giving each individual participant tools to set
granular and dynamic data sharing, privacy and access prefer-
ences. Identifying the appropriate balance between data sharing
and security/privacy will need to be addressed in the context of
existing regulatory requirements, some of which may evolve
over time.
ENGAGING PATIENTS TO PRIORITIZE RESEARCH
QUESTIONS AND DISSEMINATE RESEARCH RESULTS
PPRNs will be facilitating partnerships between participants and
researchers to generate and prioritize research questions as well
as optimize the dissemination of research results. This partner-
ship will provide an opportunity to formalize the anecdotal con-
versations participants have about important health concerns,
particularly in conditions where little is known.
One of the unique challenges the PPRNs will face is addres-
sing the different research priorities of PPRN members. While
consensus among all members may be difficult, some PPRNs are
planning in-person or online discussions of research priorities,
including focus groups, and formal methods to rank research
topics, which have been shown to be effective in differentiating
high from low priority CER topics.6
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PPRNs will identify promising approaches for disseminating
research findings to participants and providers. PPRNs have
many mechanisms for disseminating information, ranging from
traditional vehicles such as print newsletters and press releases
to innovative mechanisms such as social networking and inter-
active patient portals.
SCALING SMALL NETWORKS INTO A LARGER NETWORK
While traditional patient advocacy organizations have inten-
sively engaged with their communities, maintaining the same
level of engagement in more diverse and broad-based communi-
ties, such as PCORnet, may be challenging. Small organizations
that have built trust as a result of their long-term relationship
with the community may have a harder time sharing the more
global goals of a larger network. This may be particularly chal-
lenging for organizations that represent rare disease communi-
ties, which are often self-contained.
These challenges, however, are balanced with the advantages
of joining a larger network which offers opportunity for
expanding rare disease communities. In addition, many PPRNs
share risk factors, co-morbidities, and mechanisms of disease
that establish the value and need to integrate the data across
PPRN networks within PCORnet. While PCORnet may be able
to leverage the trust and commitment of smaller networks, iden-
tifying the value proposition for participants and incorporating
these values into well-tested outreach strategies and informed
consent documents will help sustain the trusting relationship
within PCORnet.
IDENTIFYING PATHWAYS TO SUSTAINABILITY
Patient networks that are typically based on participant-centric
service models without a robust business model may have diffi-
culty achieving financial sustainability. In PCORnet, PPRNs will
generate data to demonstrate their effectiveness and value to
participants and clinical researchers, which could lead to viable
business models and position PPRNs as competitive recipients
of future research grants.
PPRNs will need to address the issue of sustainability in the
initial offering to participants to join PCORnet. Pathways to sus-
tainability may include establishing an open-source data plat-
form, creating capacity for longitudinal data collection,
integrating EHR datasets, and encouraging ongoing open access
to the research community. PCORnet is a national resource that
will be open to all funders and investigators for use, and contin-
ued organizational support of PCORnet will be critical to
enhance and support its patient-centered goals.
CONCLUSION
By the end of the 18-month funding period, PCORnet will be
prepared to support multicenter observational and interven-
tional CER studies as well as other types of research at a
national scale. PPRNs are providing an unprecedented oppor-
tunity for patients, clinicians, and researchers to work together
in partnership in all stages of building network capacity. Despite
daunting challenges, the PPRNs are supported by a robust peer
network from which to exchange knowledge, build a set of
promising practices, and adopt or enhance novel methods. As a
result of PPRN efforts, PCORnet will be well-positioned to
support meaningful and relevant patient-centered outcomes
research that will further inform healthcare decision-making
and improve healthcare outcomes.
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